• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
JHC
Click for more information
0.00% $1.40

JAPARA HEALTHCARE LIMITED - News & Media

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Japara Healthcare Limited is an Australia-based residential aged care and retirement... Japara Healthcare Limited is an Australia-based residential aged care and retirement living provider. The Company cares for approximately 4,000 residents across 50 homes located in Victoria, New South Wales, Queensland, South Australia and Tasmania. The Company also operates five retirement villages consisting of approximately 180 independent living units (ILUs) located adjacent to five of its residential care homes. Its ILUs have fully-equipped kitchens and separate living areas and also offers additional services, such as cleaning, gardening, care services and meals. It also offers dementia support to residents.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No News & Media currently available.

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
SPC to merge with Original Juice Co and Nature One Dairy The Original Juice Co Ltd has set up a transaction which will see it merge with Aussie icon SPC Global and Singapore-based Nature One Dairy
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one Cobalt Blue has released estimates for what it would take to get its proposed Kwinana refinery off the ground, seeing CapEx of $60M.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.